“Bitcoin and the Marijuana Industry” – BG Medical Technologies CEO Speaking at National Conference, Shareholders Invited
LOS ANGELES--(BUSINESS WIRE)--BG Medical Technologies (OTC:RIGH) CEO, Angel Stanz has been invited to discuss how digital media is changing the way patients and entrepreneurs communicate about cannabis at “The State of Marijuana” event to be held on July 26th in Hollywood, California from 1pm to 9pm. This exclusive conversation with industry insiders is a unique opportunity for shareholders, emerging entrepreneurs and the public to discuss key topics with influential marijuana companies.
Medical marijuana is currently legal in 23 states, two of which have legalized cannabis for recreational use. With the imminent reform on marijuana laws nationwide, many societal and economic issues are being brought to the forefront. Mr. Stanz will join key figures and opinion leaders across business, media, and academic sectors to discuss the implications of the nation’s evolving perspectives on cannabis and what the future will hold for this controversial herb.
Mr. Stanz will participate on the Digital Media Panel discussing BG Medical development projects involving Bitcoin, and the potential impact of future payment systems on the industry. Panel discussions will also include strategies for companies looking to create online cannabis brands, digital marketing tools currently available for cannabis companies, and how new cannabis entrepreneurs can position themselves within the evolving perception of cannabis in the mainstream media.
BudGenius is offering a limited time 20% discount to this special event for all BG Medical Technologies shareholders and BudGenius.com visitors. Eligible members are encouraged to visit www.BudGenius.com to receive this discount and learn additional event information.
About BG Medical Technologies
BG Medical Technologies is a medical marijuana company that develops technology and research software for cannabis and natural health solutions. The Company collects data through a network of proprietary software, utilized by patients, by retail operators, and by medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform connecting cannabis patients to regionally available medicine that is paired to their needs. The Company operates an analytical chemistry laboratory designed for cannabis study, utilized to determine potency and safety guidance for patients and medicine manufacturers.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.